Literature DB >> 2803853

Pulmonary hypoplasia and osteogenesis imperfecta type II with defective synthesis of alpha I(1) procollagen.

J R Shapiro1, V E Burn, S D Chipman, J B Jacobs, B Schloo, L Reid, N Larsen, F Louis.   

Abstract

Perinatal lethal osteogenesis imperfecta (OI type II), a heritable disorder of connective tissue occurs approximately once in 60,000 live births. Phenotypic characteristics include defective cranial ossification and severe skeletal deformity due to intrauterine rib and long bone fractures. Lethal OI may be associated with intracranial hemorrhage or severe respiratory insufficiency. Pulmonary hypoplasia has been previously observed in OI type II, but has not been defined clinically. The infant described herein was born with OI type II and pulmonary hypoplasia. Pathological examination of airway branching patterns indicated that lung development had progressed to only the 10 week stage with immature acinar development. Investigation type I collagen synthesis by cultured dermal fibroblasts revealed the presence of electrophoretically abnormal alpha 1(I) polypeptides. These findings suggest that biochemically regulated processes, as well as mechanical factors, may impeded pulmonary development in similar cases of OI type II.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2803853     DOI: 10.1016/8756-3282(89)90049-5

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  13 in total

Review 1.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

2.  Respiratory defects in the CrtapKO mouse model of osteogenesis imperfecta.

Authors:  Milena Dimori; Melissa E Heard-Lipsmeyer; Stephanie D Byrum; Samuel G Mackintosh; Richard C Kurten; John L Carroll; Roy Morello
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-02-05       Impact factor: 5.464

3.  Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap(-/-) Mice, a Model of Recessive Osteogenesis Imperfecta.

Authors:  Ingo Grafe; Stefanie Alexander; Tao Yang; Caressa Lietman; Erica P Homan; Elda Munivez; Yuqing Chen; Ming Ming Jiang; Terry Bertin; Brian Dawson; Franklin Asuncion; Hua Zhu Ke; Michael S Ominsky; Brendan Lee
Journal:  J Bone Miner Res       Date:  2016-02-12       Impact factor: 6.741

4.  Pulmonary and diaphragmatic pathology in collagen type I α1 mutant mice with osteogenesis imperfecta.

Authors:  Carolyn J Baglole; Feng Liang; Hussein Traboulsi; Angela Rico de Souza; Christian Giordano; Josephine T Tauer; Frank Rauch; Basil J Petrof
Journal:  Pediatr Res       Date:  2018-05-09       Impact factor: 3.756

5.  A multicenter study to evaluate pulmonary function in osteogenesis imperfecta.

Authors:  Allison Tam; Shan Chen; Evan Schauer; Ingo Grafe; Venkata Bandi; Jay R Shapiro; Robert D Steiner; Peter A Smith; Michael B Bober; Tracy Hart; David Cuthbertson; Jeffrey Krischer; Mary Mullins; Peter H Byers; Robert A Sandhaus; Michaela Durigova; Francis H Glorieux; Frank Rauch; Vernon Reid Sutton; Brendan Lee; Eric T Rush; Sandesh C S Nagamani
Journal:  Clin Genet       Date:  2018-09-24       Impact factor: 4.438

6.  Generalized connective tissue disease in Crtap-/- mouse.

Authors:  Dustin Baldridge; Jennifer Lennington; MaryAnn Weis; Erica P Homan; Ming-Ming Jiang; Elda Munivez; Douglas R Keene; William R Hogue; Shawna Pyott; Peter H Byers; Deborah Krakow; Daniel H Cohn; David R Eyre; Brendan Lee; Roy Morello
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

7.  An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen.

Authors:  J R Shapiro; M L Stover; V E Burn; M B McKinstry; A L Burshell; S D Chipman; D W Rowe
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

8.  Perinatal lethal type II osteogenesis imperfecta: a case report.

Authors:  Imene Dahmane Ayadi; Emira Ben Hamida; Rania Ben Rebeh; Sihem Chaouachi; Zahra Marrakchi
Journal:  Pan Afr Med J       Date:  2015-05-05

9.  Cardiopulmonary dysfunction in the Osteogenesis imperfecta mouse model Aga2 and human patients are caused by bone-independent mechanisms.

Authors:  Frank Thiele; Christian M Cohrs; Armando Flor; Thomas S Lisse; Gerhard K H Przemeck; Marion Horsch; Anja Schrewe; Valerie Gailus-Durner; Boris Ivandic; Hugo A Katus; Wolfgang Wurst; Catherine Reisenberg; Hollis Chaney; Helmut Fuchs; Wolfgang Hans; Johannes Beckers; Joan C Marini; Martin Hrabé de Angelis
Journal:  Hum Mol Genet       Date:  2012-05-15       Impact factor: 6.150

Review 10.  Syndromes with congenital brittle bones.

Authors:  Horacio Plotkin
Journal:  BMC Pediatr       Date:  2004-08-31       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.